Antares resubmitted NDA for testosterone replacement therapy Tlando accepted by FDA
February 03 2022 - 9:26AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Antares Pharma (NASDAQ:ATRS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Antares Pharma (NASDAQ:ATRS)
Historical Stock Chart
From Sep 2023 to Sep 2024